
1. vaccine. 2007 feb 19;25(9):1658-61. epub 2006 nov 13.

intravaginal administration inactivated vaccine prevents lesions induced by
caprine herpesvirus-1 goats.

camero m(1), bellacicco al, tarsitano e, decaro n, martella v, tempesta m,
buonavoglia c.

author information: 
(1)department animal health well-being, faculty veterinary medicine,
university bari, strada p.le per casamassima km 3, 70010 valenzano, italy.

to evaluate efficacy mucosal vaccination beta-propiolactone
inactivated caprine herpesvirus-1 (cphv-1) vaccine, goats received vaginal
administrations two 7-day cycles 2 weeks intervals. seven days the
end second cycle, goats challenged intravaginally 4 ml of
virulent ba.1 strain cphv-1. vaccinated goats shed challenge virus 8 days 
but, comparison control unvaccinated-challenged goats, significantly
protected classical clinical signs genital lesions. even without
adjuvants, prolonged mucosal vaccination induced production secretory iga 
provided significant clinical protection.

doi: 10.1016/j.vaccine.2006.11.002 
pmid: 17150288  [indexed medline]

